Implicity in the news
Universal cardiac remote monitoring
Tamtam found 20 recent articles about Implicity.
- FDA clears AI software for limiting false-positive ICM alerts
Implicity secured FDA clearance for AI software that reduces false-positive alerts from implantable cardiac monitors.
- Implicity’s Next-Generation ILR ECG Analyzer Earns FDA Clearance
Implicity secured FDA clearance for its next-generation ILR ECG Analyzer, an AI algorithm that reduces false-positive alerts from implantable cardiac monitors by up to 76%.
- PODCAST : Arnaud Rosier, cardiologue, président et cofondateur d'Implicity – 18/05
AI-driven management and analysis of cardiac remote monitoring data to assist cardiologists.
- Arnaud Rosier (Implicity) : télésurveillance cardiaque par IA - 18/05
Arnaud Rosier explains how Implicity uses AI to manage cardiac remote monitoring data during an interview on BFM Business.
- Arnaud Rosier (Implicity) : télésurveillance cardiaque par IA - 18/05
Arnaud Rosier explains how his company uses artificial intelligence to manage and analyze cardiac remote monitoring data for cardiologists.
- Télésurveillance des moniteurs cardiaques: vers une prise en charge d'Implicity IM009 et une possible radiation des autres DM
Implicity's universal cardiac monitoring platform IM009 is being evaluated for French reimbursement due to its superior organizational efficiency over single-vendor systems.
- EHRA 2026 Studies Reveal Why False Positives Persist in AI-Equipped Implantable Cardiac Monitors
Clinical studies show a cloud-based AI layer can significantly reduce false-positive alerts in remote cardiac monitoring compared to standard manufacturer algorithms.
- Avec Implicity, la télésurveillance cardiaque gagne du terrain
A universal cardiac remote monitoring platform expanding its footprint across European and US medical facilities following a 23 million euro funding round.
- Rejet d'une requête administrative de Medtronic contre la "plateforme universelle" de télésurveillance cardiaque d'Implicity
A court rejected Medtronic's attempt to block Implicity's regulatory certifications for its universal cardiac monitoring software.
- How Third-Party Remote Monitoring May Redefine Outcomes for Cardiac Device Patients
Universal cardiac remote monitoring platforms reduce patient mortality and hospital costs by standardizing data from multiple device manufacturers into a single AI-powered interface.
- Implicity's EVIDENCE-RM Study Demonstrates Marked Improvement in ICD Patient Outcomes
Clinical study results prove the universal cardiac remote monitoring platform significantly reduces mortality and healthcare costs compared to traditional manufacturer systems.
- L’AP-HP a déployé pour huit de ses établissements la plateforme Implicity pour le télésuivi des patients porteurs de dispositifs cardiaques implantables
Eight AP-HP hospitals have adopted the Implicity platform to unify remote monitoring and data management for patients with heart implants.
- La start-up Implicity s'appuie sur l'IA pour révolutionner la télésurveillance cardiaque
AI-powered universal cardiac remote monitoring platform securing brand-name reimbursement and demonstrating significant reductions in patient mortality.
- Implicity, la start-up qui analyse les informations de votre pacemaker
AI-driven software filters connected pacemaker alerts and integrates with medical records to streamline remote cardiac monitoring.
- FDA issues 510(k) clearance for Implicity’s SignalHF1 algorithm
FDA cleared Implicity’s SignalHF1 algorithm to predict heart failure events using data from cardiac implantable electronic devices, enabling early intervention and reduced hospitalizations.
- Implicity Earns FDA Clearance for New Heart Failure Prediction Algorithm
FDA clearance was granted for a new AI algorithm that predicts heart failure events using data from various cardiac implantable devices.
- FDA OKs Implicity’s New Heart Failure Prediction Algorithm
FDA clears a heart failure prediction algorithm that uses data from various cardiac implants to alert physicians of high hospitalization risk two weeks in advance.
- Implicity examine une série B
Implicity is seeking Series B funding to scale its cardiac remote monitoring platform and expand US operations.
- Implicity Uses AI to Cut Through False Positive ILR Noise
FDA-cleared AI technology reduces false positive cardiac alerts by 79% for clinicians using Medtronic implantable loop recorders.
- Jon Hunt Joins Implicity as Chief Commercial Officer
Implicity appointed Jon Hunt as Chief Commercial Officer to scale its AI-powered cardiac remote monitoring business in the U.S. market.
Articles collected by Tamtam and kept when they are about the company, newest first. Each links to its source.
Selling to companies like Implicity?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies